Sponsor Pipeline

BIOHENG THERAPEUTICS US LLC Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-19 NCT07070219
A Study of CTD402 in T-ALL/LBL Patients		 Sponsor changed: BIOHENG THERAPEUTICS US LLC -> Imviva Bio
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07070219 A Study of CTD402 in T-ALL/LBL Patients Acute Lymphocytic Leukemia Refractory Recruiting
Disease Areas
Leukemia (1) Acute Lymphoblastic Leukemia (ALL) (1)
Get alerts when BIOHENG THERAPEUTICS US LLC's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free